ENvue Medical Inc. (FEED) Income Statement
FEED 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsFEED revenue and net income
Where FEED's revenue goes
2025Each bar shows an amount and its share of revenue. FEED kept −712.3% of revenue as net income.
FEED profit margins
FEED growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | −0.2% | +50.3% | +32.6% | +33.0% |
| Gross profit | −89.9% | −2.9% | −6.5% | +4.6% |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
FEED quarterly EPS vs estimates
FEED income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.6M | $2.6M | $2.3M | $752,000 | $1.7M | $623,000 | $530,000 | $318,000 | $239,000 | $229,000 |
| Cost of revenue | $2.4M | $1.1M | $746,000 | $585,000 | $925,000 | $409,000 | $249,000 | $158,000 | $88,000 | $88,000 |
| Gross profit | $153,000 | $1.5M | $1.5M | $167,000 | $770,000 | $214,000 | $281,000 | $160,000 | $151,000 | $141,000 |
| Research & development | $1.8M | $909,000 | $185,000 | $283,000 | $293,000 | $171,000 | $514,000 | $614,000 | $693,000 | $584,000 |
| Sales, general & admin | $10.1M | $4.2M | $4.8M | $4.9M | $6.2M | — | — | — | — | — |
| Total operating expenses | $11.9M | $5.1M | $5.0M | $5.2M | $6.5M | $4.9M | $5.4M | $4.5M | $3.2M | $2.5M |
| Operating income | −$11.7M | −$3.6M | −$3.4M | −$5.0M | −$5.7M | −$4.7M | −$5.2M | −$4.3M | −$3.1M | −$2.3M |
| Interest expense | $288,000 | $135,000 | $246,000 | $347,000 | $0 | $147,000 | $62,000 | — | $1.3M | $15,000 |
| Income before taxes | −$18.5M | −$3.7M | −$3.7M | −$5.4M | −$14.2M | −$4.3M | −$5.8M | −$4.3M | −$4.9M | −$2.7M |
| Income taxes | −$307,000 | $19,000 | $29,000 | $35,000 | $32,000 | $15,000 | −$17,000 | −$127,000 | $38,000 | $117,000 |
| Net income | −$18.2M | −$3.7M | −$3.7M | −$5.4M | −$14.3M | −$4.3M | −$5.8M | −$4.2M | −$5.8M | −$2.8M |
| EBITDA | −$17.6M | −$3.7M | −$3.5M | −$5.4M | −$14.2M | −$4.2M | −$5.7M | −$4.3M | −$3.6M | −$2.7M |
| EPS (diluted) | −$190.56 | −$1109.52 | −$2811.43 | −$4.04 | −$0.48 | −$12490.42 | −$4389.17 | −$16891.56 | −$22417.86 | −$6107.52 |
| Gross margin | 6.0% | 59.0% | 67.3% | 22.2% | 45.4% | 34.3% | 53.0% | 50.3% | 63.2% | 61.6% |
| Operating margin | −459.7% | −140.0% | −150.5% | −666.5% | −335.3% | −757.5% | −971.9% | −1,353.1% | −1,293.3% | −1,011.4% |
| Net margin | −712.3% | −144.8% | −162.5% | −724.5% | −842.6% | −694.2% | −1,093.2% | −1,306.3% | −2,429.3% | −1,236.2% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $239,000 | $653,000 | $312,000 | $722,000 | $494,000 | $1.0M | $444,000 | $376,000 | $817,000 | $921,000 | $1.2M | $458,000 |
| Cost of revenue | $505,000 | $708,000 | $682,000 | $533,000 | $529,000 | $656,000 | $161,000 | $243,000 | $389,000 | $257,000 | $440,000 | $109,000 |
| Gross profit | −$266,000 | −$55,000 | −$370,000 | $189,000 | −$35,000 | $369,000 | $283,000 | $133,000 | $428,000 | $664,000 | $737,000 | $349,000 |
| Research & development | $510,000 | $468,000 | $39,000 | $221,000 | $972,000 | $530,000 | $352,000 | $249,000 | $187,000 | $121,000 | $62,000 | $33,000 |
| Sales, general & admin | $4.7M | $3.2M | $3.3M | $2.2M | $3.0M | $1.7M | $1.3M | $854,000 | — | — | — | — |
| Total operating expenses | $5.2M | $3.7M | $3.3M | $2.4M | $3.9M | $2.2M | $1.7M | $1.1M | $1.1M | $1.2M | $1.4M | $1.0M |
| Operating income | −$5.5M | −$3.7M | −$3.7M | −$2.2M | −$4.0M | −$1.9M | −$1.4M | −$970,000 | −$674,000 | −$568,000 | −$702,000 | −$670,000 |
| Interest income | $603,000 | — | — | — | $211,000 | — | — | — | — | — | — | — |
| Interest expense | $120,000 | $36,000 | $38,000 | $53,000 | $144,000 | $63,000 | $34,000 | $33,000 | $55,000 | $13,000 | $100,000 | $54,000 |
| Income before taxes | −$4.9M | −$3.8M | −$13.3M | $545,000 | −$3.9M | −$2.5M | −$1.4M | −$995,000 | −$684,000 | −$581,000 | −$802,000 | −$724,000 |
| Income taxes | −$2,000 | $33,000 | −$419,000 | $35,000 | $62,000 | $15,000 | $5,000 | $3,000 | $4,000 | $7,000 | $11,000 | $3,000 |
| Net income | −$4.9M | −$3.8M | −$12.9M | $600,000 | −$156,000 | −$2.5M | −$1.4M | −$998,000 | −$688,000 | −$588,000 | −$813,000 | −$727,000 |
| EBITDA | −$5.3M | −$3.5M | −$6.5M | $855,000 | −$3.4M | −$2.4M | −$1.4M | −$995,000 | −$683,000 | −$568,000 | −$702,000 | −$670,000 |
| EPS (diluted) | −$1.98 | −$82.53 | −$148.56 | −$1.12 | −$1.03 | −$39.85 | −$4.21 | −$469.95 | −$326.17 | −$309.19 | −$524.44 | −$557.60 |
| Gross margin | −111.3% | −8.4% | −118.6% | 26.2% | −7.1% | 36.0% | 63.7% | 35.4% | 52.4% | 72.1% | 62.6% | 76.2% |
| Operating margin | −2,290.4% | −568.3% | −1,173.1% | −311.2% | −804.9% | −180.7% | −308.6% | −258.0% | −82.5% | −61.7% | −59.6% | −146.3% |
| Net margin | −2,049.8% | −585.3% | −4,119.2% | 83.1% | −31.6% | −243.4% | −322.3% | −265.4% | −84.2% | −63.8% | −69.1% | −158.7% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in FEED's financial statements (latest annual report filed December 31, 2025); data from EODHD. Sales, general & administrative expenses include sales and marketing.
FEED financial results
In fiscal year 2025 (ended December 31, 2025), ENvue Medical reported revenue of $2.6 million, down 0.2% from the year before. It had a net loss of $18.2 million, a net profit margin of −712.3%. Diluted earnings per share came to −$190.56. Over five years revenue grew at an average rate of 32.6% a year.
See the FEED stock overview for the latest quote and news, or the FEED chart for price history and technical indicators.
FEED income statement FAQ
What is ENvue Medical's annual revenue?
ENvue Medical reported total revenue of $2.6 million for fiscal year 2025, which ended on December 31, 2025. That was down 0.2% from $2.6 million the previous year.
Is ENvue Medical profitable?
No. ENvue Medical reported a net loss of $18.2 million in fiscal 2025, a net profit margin of −712.3%; its operating margin was −459.7%.
What is ENvue Medical's gross margin?
ENvue Medical's gross margin was 6.0% in fiscal 2025: for every $100 of revenue, ENvue Medical kept $6 after the direct cost of its products and services.
How much does ENvue Medical spend on research and development?
ENvue Medical spent $1.8 million on research and development in fiscal 2025, 69.0% of revenue.
How fast is ENvue Medical growing?
Revenue grew 32.6% a year on average over the last five fiscal years, from $0.6 million to $2.6 million.
What are ENvue Medical's earnings per share?
ENvue Medical earned $-190.56 per diluted share in fiscal 2025, compared with $-1109.52 a year earlier.
When does ENvue Medical's fiscal year end?
ENvue Medical's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on December 31, 2025.